QUEST DIAGNOSTICS INC
DGXHealthcarequestdiagnostics.com
Latest available resultsSeptember 30, 2026Quarter · 10-Q filed Oct 23, 2026
Next reportFebruary 8, 2027after close · forecast 2.706 $/share
Revenue
$3.10B
▲ +10.0% vs prior year YoY
Net income
$312.00M
▲ +27.3% vs prior year YoY
EPS
2.78$
▲ +28.7% vs prior year YoY
Net margin
10.1%
▲ +1.4 pp vs prior year YoY
Revenue▲ +10.0%
Margins (% of revenue)GrossOperatingNet
Net income▲ +27.3%
EPS▲ +28.7%
Financial statements
View 10-Q filed October 23, 2026 on SEC ↗| Metric | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $2.62B | $2.65B | $2.76B | $2.82B | $2.81B | $2.90B | $3.04B | $3.10B | ▲ +10.0% |
| Gross profit | $858.00M | $863.00M | $943.00M | $949.00M | $910.00M | $942.00M | $1.03B | $1.04B | ▲ +9.8% |
| Operating income | $361.00M | $346.00M | $438.00M | $386.00M | $386.00M | $399.00M | $459.00M | $479.00M | ▲ +24.1% |
| Net income | $222.00M | $220.00M | $282.00M | $245.00M | $245.00M | $252.00M | $320.00M | $312.00M | ▲ +27.3% |
| R&Dnever filed | — | — | — | — | — | — | — | — | — |
| EPS (diluted) | — | 1.94 $ | 2.47 $ | 2.16 $ | — | 2.24 $ | 2.84 $ | 2.78 $ | ▲ +28.7% |
| Margins (% of revenue) | |||||||||
| Gross | 32.7 % | 32.5 % | 34.2 % | 33.7 % | 32.4 % | 32.5 % | 33.7 % | 33.6 % | ▼ -0.1 pt |
| Operating | 13.8 % | 13.0 % | 15.9 % | 13.7 % | 13.8 % | 13.8 % | 15.1 % | 15.5 % | ▲ +1.8 pt |
| Net | 8.5 % | 8.3 % | 10.2 % | 8.7 % | 8.7 % | 8.7 % | 10.5 % | 10.1 % | ▲ +1.4 pt |
| Balance sheet | |||||||||
| Assets | $16.15B | $15.80B | $15.97B | $16.20B | $16.23B | $16.67B | $16.94B | $17.22B | ▲ +6.3% |
| Liabilities | $9.34B | $8.84B | $8.70B | $8.90B | $9.02B | $9.01B | $9.12B | $9.27B | ▲ +4.1% |
| Equity | $6.81B | $6.96B | $7.26B | $7.29B | $7.21B | $7.67B | $7.82B | $7.95B | ▲ +9.0% |
| Cash | $549.00M | $188.00M | $319.00M | $432.00M | $420.00M | $393.00M | $626.00M | $797.00M | ▲ +84.5% |
| Capital | |||||||||
| Shares outstanding | 110.98M | 111.64M | 111.82M | 111.24M | 109.87M | 110.70M | 110.37M | 110.02M | ▼ -1.1% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.